IBRX
#834
ImmunityBio, Inc. - Common Stock
10.5 1 USD
+0.06%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+6.05%
Variación mensual
+33.21%
Variación en los últimos 6 meses
+43.97%
Cambio anual
+341.60%
Cierres anteriores
9.9 1
Open
9.9 9
Mínimo
9.8 7
Máximo
10.8 0
Financials
- Market Capitalization 11.14 B
- Employee 691
- Founded 2014
- CEO Rich Adcock
- Website www.immunitybio.com
- Headquarter Delaware, United States
- FIGI BBG007T9DYW9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.21
Relación precio/flujo de caja
16.08
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 774 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 110.42 USD | +0.53% | +0.70% | +2.24% | +65.30% | 12.53 B USD | ||
| 829 |  TECH Bio-Techne Corp - Common Stock | 72.46 USD | +0.01% | +0.07% | +0.35% | +22.09% | 11.36 B USD | ||
| 847 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 471.75 USD | -1.08% | -6.58% | -12.64% | +11.36% | 10.90 B USD | ||
| 857 |  PCVX Vaxcyte, Inc. - Common Stock | 71.38 USD | +9.78% | -18.15% | +18.89% | +68.75% | 10.62 B USD |